Successful treatment of ulcerative necrobiosis lipoidica with JAK inhibitor

Erfurt-Berge C, Sticherling M (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Journal of the European Academy of Dermatology and Venereology Wiley-Blackwell

DOI: 10.1111/jdv.16297

Abstract

Necrobiosis lipoidica (NL) is a rare granulomatous disease that predominantly affects middle aged women and is often associated with diabetes mellitus and other metabolic disorders 1 . About 30 % of the patients develop ulcerations within NL lesions on the lower leg, which complicate the course of disease and are often recalcitrant to standard wound care procedures 2 . Systemic therapies for NL are reported only for single cases or in small case series with varying outcome 3 . Randomized controlled trials are missing due to the character of NL as an orphan disease.

Authors with CRIS profile

Cornelia Erfurt-Berge Department of Dermatology Michael Sticherling Professur für Dermatologie

How to cite

APA:

Erfurt-Berge, C., & Sticherling, M. (2020). Successful treatment of ulcerative necrobiosis lipoidica with JAK inhibitor. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.16297

MLA:

Erfurt-Berge, Cornelia, and Michael Sticherling. "Successful treatment of ulcerative necrobiosis lipoidica with JAK inhibitor." Journal of the European Academy of Dermatology and Venereology (2020).

BibTeX: Download